e-learning
resources
Vienna 2009
Monday, 14.09.2009
Diagnostic advances in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis
R. Sales, F. Vargas, M. Acencio, K. Uezumi, E. Genofre, M. Seiscento, L. Antonangelo (Sao Paulo, Brazil)
Source:
Annual Congress 2009 - Diagnostic advances in tuberculosis
Session:
Diagnostic advances in tuberculosis
Session type:
Thematic Poster Session
Number:
2535
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Sales, F. Vargas, M. Acencio, K. Uezumi, E. Genofre, M. Seiscento, L. Antonangelo (Sao Paulo, Brazil). Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis. Eur Respir J 2009; 34: Suppl. 53, 2535
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions
Source: Eur Respir J 2005; 25: 104-109
Year: 2005
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation
Source: Eur Respir J 2009; 33: 134-141
Year: 2009
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Matrix metalloproteinases in tuberculosis
Source: Eur Respir J 2011; 38: 456-464
Year: 2011
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007
Matrix metalloprotease-1 and tissue inhibitor of metalloprotease-1 levels in pleural effusions of different origins
Source: Eur Respir J 2004; 24: Suppl. 48, 82s
Year: 2004
Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012
Matrix metalloproteinases in pulmonary fibrosis
Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis
Year: 2013
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 834-842
Year: 2005
System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction)
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo
Source: Eur Respir J 2002; 20: 170-176
Year: 2002
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006
Expression of elastolytic matrix metalloproteinases in bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 228s
Year: 2002
Metalloproteinases in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 38: 1461-1467
Year: 2011
Prognostic role of matrix metalloproteinase system / inhibitors in assessing the nature of reparative changes in infiltrative pulmonary tuberculosis (ITL).
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept